AI Stock Memo: BLCO - Bausch + Lomb - RankAlpha

BLCO

AI Memo

Bausch + Lomb

As of 2026-02-19/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-02-19 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Next quarterly earnings release (est.) • 2026-05-20

Expected move: +12%

Biggest risk

Execution delays, weak surgical/retail demand, or regulatory setbacks compress margins and market share, driving the stock toward the analyst low near $13 as estimates are revised down [#SERP-4].

Invalidation

Break below $13 or thesis failure.

What would change my mind?

Successful new-product rollouts and faster-than-expected margin expansion lift revenue above consensus, prompting a rerating toward the low–mid $20s as specialty products scale and pricing power improves [#SERP-8].

Research note

Recommendation

—

Confidence

medium

As of

2026-02-19

Base target

$18

p=60%

Bull target

$22

p=20%

Bear target

$13

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Operational / margin guidance update
Broader market-share gains in specialty eye-care
Successful new-product rollouts and faster-than-expected margin expansion lift revenue above consensus, prompting a rerating toward the low–mid $20s as specialty products scale and pricing power improves [#SERP-8].

BearKey bullets

Earnings miss or weak FY guidance
Margin pressure from input-costs or supply disruption
Regulatory or product-safety issues on key SKUs

WatchKey bullets

Next quarterly earnings release (est.)

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $18 (p=60%)

Bull/Bear spread: +41% / -17%

Vs latest close: Bull +41% · Base +12% · Bear -17%

Scenario probabilities

Bull Target: $22 (p=20%)Base Target: $18 (p=60%)Bear Target: $13 (p=20%)

Commentary

Consensus targets cluster in the mid-$17s, producing a neutral-to-cautious market tone ahead of near-term results [#SERP-4], [#SERP-1]. Short-term moves will depend on the upcoming print and any guidance/analyst reactions; sustained margin improvement is necessary to shift sentiment meaningfully higher [#SERP-7].

As of 2026-02-19 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Execution delays, weak surgical/retail demand, or regulatory setbacks compress margins and market share, driving the stock toward the analyst low near $13 as estimates are revised down [#SERP-4].

Drivers

Scannable catalysts and supporting factors

Operational / margin guidance update
Broader market-share gains in specialty eye-care

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-02-19Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$17.38

Range (USD)

$13.00 - $21.00

Count

Query: Bausch + Lomb Corp Common (BLCO) analyst consensus price target high low average

Bausch + Lomb (BLCO) Stock Forecast & Price Target - Investing.com
Search result #1
According to projections from 14 analysts, the average 12-month price target for Bausch + Lomb is 17.54, with a high estimate of 21 and a low estimate of 13.
Open source
Bausch + Lomb Corporation: Target Price Consensus and Analysts ...
Search result #2
Mean consensus. OUTPERFORM ; Number of Analysts. 15 ; Last Close Price. 17.73USD ; Average target price. 17.61USD ; Spread / Average Target. -0.69%.
Extracted: $17.73, $17.61Open source
Bausch + Lomb Corporation (BLCO) Stock Price, News, Quote ...
Search result #3
Analyst Stifel. Rating Action Maintains. Rating Hold. Price Action Raises. Price Target 14 -> 15. View More. Statistics: BLCO. View More. Valuation Measures.
Open source
Bausch + Lomb Corp. Analyst Estimates - BLCO - MarketWatch
Search result #4
Stock Price Targets. High, $21.00. Median, $17.00. Low, $13.00. Average, $17.54. Current Price, $16.41. Yearly Numbers. Estimates. BLCO will report 2025 ...
Extracted: $21.00, $17.00, $13.00, $17.54, $16.41Open source
BLCO Stock Forecast - Bausch + Lomb Corp - Alpha Spread
Search result #5
17.51 USD. According to Wall Street analysts, the average 1-year price target for BLCO is 17.51 USD with a low forecast of 13.13 USD and a high forecast of 22. ...
Extracted: $17.51, $13.13Open source
BLCO, Bausch + Lomb Corp - Stock Analyst Price Targets - AnaChart
Search result #6
BLCO is currently covered by 10 analysts with an average price target of $19.14. ... What is BLCO (Bausch + Lomb Corp) average time for price targets to be met?
Extracted: $19.14Open source

Scenarios

Bull Target (Scenario probability)

$22 / p=20% prob

Base Target (Scenario probability)

$18 / p=60% prob

Bear Target (Scenario probability)

$13 / p=20% prob

Price $16 as of 2026-05-29

Nearest Scenario: Base (∆ 12%)

Targets vs latest close: Bull +41% · Base +12% · Bear -17%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-05-20
Next quarterly earnings release (est.)
Quarterly results and updated FY guidance can drive a directional move; consensus targets and recent analyst notes show tight clustering around mid-$17s which could amplify volatility around the print [#SERP-4], [#SERP-2]. Date is estimated conservatively pending official IR schedule.
Prob 85.00% • Move 8.00% • Priced-in 65.00%

Short-term Catalysts

Next few weeks

Operational / margin guidance update
2026-05-20
Management commentary on cost savings, mix shifts, or manufacturing efficiencies could materially alter near-term margins and re-rate multiples; analysts currently reflect only modest upside [#SERP-1], [#SERP-5].
Prob 45% • Move 6% • Priced-in 40%

Long-term Catalysts

Months to a year

Broader market-share gains in specialty eye-care
2027-02-19
Sustained share gains in contact lenses and ophthalmic surgical supplies or successful new-product uptake could drive multi-quarter upside; this outcome is execution-dependent and not fully reflected in consensus [#SERP-7], [#SERP-8].
Prob 35% • Move 25% • Priced-in 20%

Risks

Earnings miss or weak FY guidance
Margin pressure from input-costs or supply disruption
Regulatory or product-safety issues on key SKUs
Slower-than-expected new-product adoption

Peers

Symbol	Summary
ALC	Alcon — large ophthalmic-device player; useful comp for surgical supplies, lenses and premium pricing comparisons.
COO	CooperCompanies — contact-lens and specialty eye-care peer with similar channel exposure and product-cycle sensitivity.
JNJ	Johnson & Johnson — broad healthcare benchmark; Vision segment offers a defensive comparator for margins and scale benefits.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Bausch + Lomb Corp Common (BLCO) analyst consensus price target high low average
Analysis date: 2026-02-19